E1A (Targeted Genetics)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameE1A (Targeted Genetics)
Drug Alias Namelipid-polycation-DNA gene transfer system (Targeted Genetics/University of Pittsburgh)liposome-entrapped polycation-condensed DNA (Targeted Genetics/University of Pittsburgh)targeted LPD-PEG (Targeted Genetics/Emerald)tgLOC71LPD vectors (Targeted Genetics/University of Pittsburgh) +[7] 
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmerald Gene SystemsUniversity Of PittsburghArmata Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A